Clinical trial
Prospective Study to Analyze Ninjurin-1 and Its Soluble Part During Systemic Inflammation
NCT02079597 is registered in ClinicalTrials.gov with Dr. Patrick Meybohm, M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study to Analyze Ninjurin-1 and Its Soluble Part During Systemic Inflammation
- Lead sponsor
- Dr. Patrick Meybohm, M.D.
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- September 30, 2014
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ninj1 expression, sirs